501 related articles for article (PubMed ID: 14665612)
1. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
2. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
Moschos SJ; Kirkwood JM; Konstantinopoulos PA
J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
[No Abstract] [Full Text] [Related]
3. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.
Hancock BW; Wheatley K; Harris S; Ives N; Harrison G; Horsman JM; Middleton MR; Thatcher N; Lorigan PC; Marsden JR; Burrows L; Gore M
J Clin Oncol; 2004 Jan; 22(1):53-61. PubMed ID: 14665609
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant interferon therapy for melanoma.
Hancock B; Wheatley K; Ives N; Gore M
J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
[No Abstract] [Full Text] [Related]
6. Current management of melanoma: benefits of surgical staging and adjuvant therapy.
McMasters KM; Swetter SM
J Surg Oncol; 2003 Mar; 82(3):209-16. PubMed ID: 12619066
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant high-dose interferon-alpha therapy for high-risk melanoma.
Kirkwood JM; Tarhini AA
Forum (Genova); 2003; 13(2):127-40; quiz 187-8. PubMed ID: 14732880
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant interferon treatment of melanoma].
Török L
Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
[TBL] [Abstract][Full Text] [Related]
9. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
Kimyai-Asadi A; Usman A
J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
[TBL] [Abstract][Full Text] [Related]
10. Duration of high-dose interferon alpha-2b regimen for resected high-risk melanoma.
Agarwala SS; Gray RJ; Wong MK
J Clin Oncol; 2009 Sep; 27(25):e82-3; author reply e84. PubMed ID: 19635995
[No Abstract] [Full Text] [Related]
11. How does interferon work? Does it even matter?
Sondak VK
Cancer; 2002 Sep; 95(5):947-9. PubMed ID: 12209676
[No Abstract] [Full Text] [Related]
12. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
13. Current therapy of cutaneous melanoma.
Mays SR; Nelson BR
Cutis; 1999 May; 63(5):293-8. PubMed ID: 10349545
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha as adjuvant postsurgical treatment of melanoma: a meta-analysis.
Pirard D; Heenen M; Melot C; Vereecken P
Dermatology; 2004; 208(1):43-8. PubMed ID: 14730236
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy for melanoma.
Sondak VK
Cancer J; 2001; 7 Suppl 1():S24-7. PubMed ID: 11504282
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous melanoma: interferon alpha adjuvant therapy for patients at high risk for recurrent disease.
Lens M
Dermatol Ther; 2006; 19(1):9-18. PubMed ID: 16405565
[TBL] [Abstract][Full Text] [Related]
17. How melanoma is treated in real life.
Dummer R; Schadendorf D
Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
[No Abstract] [Full Text] [Related]
18. [Treatment of primary and regional melanoma].
Dreno B
Rev Prat; 2004 Jun; 54(11):1203-9. PubMed ID: 15496027
[TBL] [Abstract][Full Text] [Related]
19. [Current therapy of carcinoma of the skin].
Dummer R; Goldinger SM; Sailer E; French LE
Ther Umsch; 2010 Sep; 67(9):447-52. PubMed ID: 20806173
[TBL] [Abstract][Full Text] [Related]
20. Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials.
Wheatley K; Ives N; Hancock B; Gore M; Eggermont A; Suciu S
Cancer Treat Rev; 2003 Aug; 29(4):241-52. PubMed ID: 12927565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]